Department of Paediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, Hannover, Germany.
Department of Paediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany; Department of Neurology, University Medicine Essen, Essen, Germany.
J Allergy Clin Immunol. 2021 Jun;147(6):2281-2294.e7. doi: 10.1016/j.jaci.2020.09.041. Epub 2020 Nov 27.
Asthma is a widespread, multifactorial chronic airway disease. The influence of regulatory B cells on airway hyperreactivity (AHR) and remodeling in asthma is poorly understood.
Our aim was to analyze the role of B cells in a house dust mite (HDM)-based murine asthma model.
The influence of B cells on lung function, tissue remodeling, and the immune response were analyzed by using wild-type and B-cell-deficient (μMT) mice and transfer of IL-10-proficient and IL-10-deficient B cells to μMT mice.
After HDM-sensitization, both wild-type and μMT mice developed AHR, but the AHR was significantly stronger in μMT mice, as confirmed by 2 independent techniques: invasive lung function measurement in vivo and examination of precision-cut lung slices ex vivo. Moreover, airway remodeling was significantly increased in allergic μMT mice, as shown by enhanced collagen deposition in the airways, whereas the numbers of FoxP3 and FoxP3 IL-10-secreting regulatory T cells were reduced. Adoptive transfer of IL-10-proficient but not IL-10-deficient B cells into μMT mice before HDM-sensitization attenuated AHR and lung remodeling. In contrast, FoxP3 regulatory T cells were equally upregulated by transfer of IL-10-proficient and IL-10-deficient B cells.
Our data in a murine asthma model illustrate a central role of regulatory B cells in the control of lung function and airway remodeling and may support future concepts for B-cell-targeted prevention and treatment strategies for allergic asthma.
哮喘是一种广泛存在的、多因素的慢性气道疾病。调节性 B 细胞对气道高反应性(AHR)和哮喘重塑的影响尚不清楚。
我们旨在分析 B 细胞在屋尘螨(HDM)诱导的哮喘小鼠模型中的作用。
通过使用野生型和 B 细胞缺陷型(μMT)小鼠以及向 μMT 小鼠转输白细胞介素-10(IL-10)高效和 IL-10 缺陷型 B 细胞,分析 B 细胞对肺功能、组织重塑和免疫反应的影响。
在 HDM 致敏后,野生型和 μMT 小鼠均发生 AHR,但 μMT 小鼠的 AHR 明显更强,这通过 2 种独立技术得到证实:体内侵袭性肺功能测量和体外精密切割肺切片检查。此外,过敏性 μMT 小鼠的气道重塑明显增加,表现为气道中胶原沉积增加,而 FoxP3 和 FoxP3 IL-10 分泌调节性 T 细胞的数量减少。在 HDM 致敏前向 μMT 小鼠转输 IL-10 高效但不是 IL-10 缺陷型 B 细胞可减轻 AHR 和肺重塑。相比之下,转输 IL-10 高效和 IL-10 缺陷型 B 细胞均可同等上调 FoxP3 调节性 T 细胞。
我们在哮喘小鼠模型中的数据表明,调节性 B 细胞在控制肺功能和气道重塑方面发挥着核心作用,并可能支持未来针对过敏性哮喘的 B 细胞靶向预防和治疗策略的概念。